Burzynski Research Institute
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Burzynski Research Institute sits in the top decile of US sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count).
Burzynski Research Institute: 52 sponsored US clinical trials, none currently recruiting.
Burzynski Research Institute sponsors 52 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 13 completed. 0 of these trials are in Phase 3-4 (later-stage) and 52 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Glioblastoma Multiforme of the Brain, with 1 trials.
Top-decile sponsor footprint
Burzynski Research Institute ranks in the top decile of sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 52 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (25.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
52 total, page 2 of 2
Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
NCT00003530
Antineoplaston Therapy in Treating Patients With Ependymoma
NCT00003479
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 52 |
Therapeutic Areas
How the Burzynski Research Institute early-phase archive is shaped
52 indexed studies, none listed as recruiting (0% open); 13 completed (25%).
Phase mix: 0 late (III/IV) vs 52 early (I/II) (early-phase heavy).
Top condition: Glioblastoma Multiforme of the Brain (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Burzynski Research Institute: archived-pipeline peers nationwide
Peers matched on 52 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Burzynski Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 52 archived trials
- Albany Medical College · 52 trials · 13% recruiting
- Dr. Reddy's Laboratories Limited · 52 trials · 0% recruiting
- PTC Therapeutics · 52 trials · 2% recruiting
- Spectrum Pharmaceuticals · 52 trials · 2% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Burzynski Research Institute page
52 registered trials is a research-attention snapshot, not an endorsement of Burzynski Research Institute or any single study.
- None of Burzynski Research Institute's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Glioblastoma Multiforme of the Brain is the condition Burzynski Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Glioblastoma Multiforme of the Brain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Burzynski Research Institute pipeline card: 52 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.